These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1659288)
1. Effect of the selective leukotriene B4 antagonists U-75302 and Ly255283 on bronchoalveolar eosinophilia induced by inhalation of leukotriene B4 or allergen in brown-Norway rats. Richards IM; Shields SK; Johnson RA; Smith HW Ann N Y Acad Sci; 1991; 629():428-9. PubMed ID: 1659288 [No Abstract] [Full Text] [Related]
2. Contribution of leukotriene B4 to airway inflammation and the effect of antagonists. Richards IM; Sun FF; Taylor BM; Shields SK; Griffin RL; Morris J; Wishka DG; Smith HW; Johnson RA; Dunn CJ Ann N Y Acad Sci; 1991; 629():274-87. PubMed ID: 1659282 [TBL] [Abstract][Full Text] [Related]
3. Novel inhibitors of pulmonary eosinophil accumulation. Richards IM; Shields SK; Bienkowski MJ; Dunn CJ; Jacobsen EJ Agents Actions Suppl; 1991; 34():359-68. PubMed ID: 1665309 [TBL] [Abstract][Full Text] [Related]
4. Effect of the selective leukotriene B4 antagonist U-75302 on antigen-induced bronchopulmonary eosinophilia in sensitized guinea pigs. Richards IM; Griffin RL; Oostveen JA; Morris J; Wishka DG; Dunn CJ Am Rev Respir Dis; 1989 Dec; 140(6):1712-6. PubMed ID: 2557787 [TBL] [Abstract][Full Text] [Related]
5. Receptor antagonism of leukotriene B4 myotropic activity by the 2,6 disubstituted pyridine analog U-75302: characterization on lung parenchyma strips. Lawson CF; Wishka DG; Morris J; Fitzpatrick FA J Lipid Mediat; 1989; 1(1):3-12. PubMed ID: 2562431 [TBL] [Abstract][Full Text] [Related]
6. Biological activity of leukotriene B4 analogs: inhibition of guinea pig eosinophil migration in vitro by the 2,6-disubstituted pyridine analogs U-75,302 and U-75,485. Taylor BM; Crittenden NJ; Bruden MN; Wishka DG; Morris J; Richards IM; Sun FF Prostaglandins; 1991 Sep; 42(3):211-24. PubMed ID: 1664113 [TBL] [Abstract][Full Text] [Related]
8. Modulation of leukotriene B4 receptor-1 expression by dexamethasone: potential mechanism for enhanced neutrophil survival. Stankova J; Turcotte S; Harris J; Rola-Pleszczynski M J Immunol; 2002 Apr; 168(7):3570-6. PubMed ID: 11907121 [TBL] [Abstract][Full Text] [Related]
9. A novel leukotriene B4-receptor antagonist in endotoxin shock: a prospective, controlled trial in a porcine model. Fink MP; O'Sullivan BP; Menconi MJ; Wollert PS; Wang H; Youssef ME; Fleisch JH Crit Care Med; 1993 Dec; 21(12):1825-37. PubMed ID: 8252886 [TBL] [Abstract][Full Text] [Related]
10. [Involvement of leukotrine B4 receptors in the inflammatory responses and immunological regulation in vitro]. Han CG; Huang HG; Hu M; Luo WY; Gao Y; Wang Q; Liu YX Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2009 May; 25(2):273-6. PubMed ID: 21189570 [TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 regulates proliferation and differentiation of cultured rat myoblasts via the BLT1 pathway. Sun R; Ba X; Cui L; Xue Y; Zeng X Mol Cells; 2009 Apr; 27(4):403-8. PubMed ID: 19390820 [TBL] [Abstract][Full Text] [Related]
12. Antagonism of leukotriene B4 receptors does not limit canine myocardial infarct size. Hahn RA; MacDonald BR; Simpson PJ; Potts BD; Parli CJ J Pharmacol Exp Ther; 1990 Apr; 253(1):58-66. PubMed ID: 2158553 [TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones. Herron DK; Goodson T; Bollinger NG; Swanson-Bean D; Wright IG; Staten GS; Thompson AR; Froelich LL; Jackson WT J Med Chem; 1992 May; 35(10):1818-28. PubMed ID: 1316967 [TBL] [Abstract][Full Text] [Related]
14. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells. Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240 [TBL] [Abstract][Full Text] [Related]
15. Commonly used leukotriene B4 receptor antagonists possess intrinsic activity as agonists in human endothelial cells: Effects on calcium transients, adhesive events and mediator release. Johansson AS; Haeggström JZ; Palmblad J Prostaglandins Leukot Essent Fatty Acids; 2011; 84(3-4):109-12. PubMed ID: 21183325 [TBL] [Abstract][Full Text] [Related]
16. Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Bäck M; Bu DX; Bränström R; Sheikine Y; Yan ZQ; Hansson GK Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17501-6. PubMed ID: 16293697 [TBL] [Abstract][Full Text] [Related]
17. Endothelium-dependent vascular responses induced by leukotriene B4. Bäck M; Sakata K; Qiu H; Haeggström JZ; Dahlén SE Prostaglandins Other Lipid Mediat; 2007 May; 83(3):209-12. PubMed ID: 17481557 [TBL] [Abstract][Full Text] [Related]
18. Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents. Falcone RC; Aharony D J Pharmacol Exp Ther; 1990 Nov; 255(2):565-71. PubMed ID: 2173748 [TBL] [Abstract][Full Text] [Related]
19. LY255283, a novel leukotriene B4 receptor antagonist, limits activation of neutrophils and prevents acute lung injury induced by endotoxin in pigs. Wollert PS; Menconi MJ; O'Sullivan BP; Wang H; Larkin V; Fink MP Surgery; 1993 Aug; 114(2):191-8. PubMed ID: 8393594 [TBL] [Abstract][Full Text] [Related]
20. Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist. Herron DK; Whitesitt CA; Mallet BE; Rinkema LE; Haisch KD; Fleisch JH Drugs Exp Clin Res; 1988; 14(5):303-10. PubMed ID: 2851426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]